Elsholtzia bodinieri Vaniot, perennial herbs, a traditional Yunnan Chinese herbal medicine. Its whole herb can be used as commonly used herbs to cure fever, headache, inflammation, indigestion etc., and its tender tip can also be used as tea in Yunnan of China. However, the protective mechanism of Elsholtzia bodinieri Vaniot on acute lung injury (ALI) still needs to be explored. ALI is characterized by acute respiratory inflammation, which remains a significant source of morbidity and mortality. The current study with the aim of determining the therapeutic the efficacy of E. bodinieri Vaniot on lipopolysaccharide-induced ALI, moreover uncovered the underlying gene-regulated framework, so E. bodinieri Vaniot might serve as functional food for adjuvant therapy or therapeutic agent. These potential pharmacological targets of E. bodinieri Vaniot against ALI were analyzed by multiple bioinformatics databases. E. bodinieri Vaniot methanol extract (EBE) was obtained by ultrasonic-assisted extraction method, and detected by UHPLC-ESI-HRMS/MS. These pyroptosis, inflammation and oxidative stress associated factors were measured using ELISA assay, western blotting, and histopathological examination to assess the effects of EBE. EcoTyper and immunofluorescence staining were employed to estimate macrophage polarization states in ALI lungs tissue. In ALI lung tissues, EBE treatment could increase B cell leukemia/lymphoma 2 (BCL2) to inhibit pyroptosis, downregulate prostaglandin-endoperoxide synthase 2 (PTGS2) to attenuate inflammation, upregulating NAD(P)H dehydrogenase, quinone 1 (NQO1) to alleviate oxidative stress and induce macrophage polarization toward the M2 phenotype. E. bodinieri Vaniot ameliorated ALI thought regulating pyroptosis, inflammation, oxidative stress and macrophage polarization, as well as could be a promising source for therapeutic agent.
Acute lung injury (ALI) is a clinical respiratory disease caused by various factors, which lacks effective pharmacotherapy to reduce the mortality rate. Elsholtzia bodinieri Vaniot is an annual herbaceous plant used as a traditional herbal tea and folk medicine. Here we used bioinformatic databases and software to explore and analyze the potential key genes in ALI regulated by E. bodinieri Vaniot, including B cell leukemia/lymphoma 2 (Bcl2), prostaglandin-endoperoxide synthase 2 (Ptgs2) and NAD(P)H dehydrogenase, quinone 1 (Nqo1). In an inflammatory cells model, we verified bioinformatics results, and further mechanistic analysis showed that methanol extract of E. bodinieri Vaniot (EBE) could alleviate oxidative stress by upregulating the expression of NQO1, suppress pyroptosis by upregulating the expression of BCL2, and attenuate inflammation by downregulating the expression of PTGS2. In sum, our results demonstrated that EBE treatment could alleviate oxidative stress, suppress pyroptosis and attenuate inflammation by regulating NQO1, BCL2 and PTGS2 in a cells model, and E. bodinieri Vaniot might be a promising source for functional food or as a therapeutic agent.
The mammary gland undergoes intensive remodeling during the lactation cycle, and the involution process of mammary gland contains extensive epithelial cells involved in the process of autophagy. Our studies of mice mammary glands suggest that miR-30a-3p expression was low during involution compared with its high expression in the mammary glands of lactating mice. Then, we revealed that miR-30a-3p negatively regulated autophagy by autophagy related 12 (Atg12) in mouse mammary gland epithelial cells (MMECs). Restoring ATG12, knocking down autophagy related 5 (Atg5), starvation, and Rapamycin were used to further confirm this conclusion. Overexpression of miR-30a-3p inhibited autophagy and altered mammary structure in the involution of the mammary glands of mice, which was indicative of alteration in mammary remodeling. Taken together, these results elucidated the molecular mechanisms of miR-30a-3p as a key induction mediator of autophagy by targeting Atg12 within the transition period between lactation and involution in mammary glands.
Pancreatitis is a prevalent disorder of the digestive system, characterized by the rapid onset of pancreatic exudative edema and acinar cell necrosis. Clinically, the pathogenesis of pancreatitis is multifactorial and involves an intricate interplay among oxidative stress, dysregulated inflammatory signaling pathways, impaired autophagy, and aberrant apoptosis. Currently, no targeted disease-modifying pharmacotherapies are approved for clinical use in pancreatitis. In recent years, natural products have garnered increasing attention due to their inherent advantages, including chemical diversity, multi-target engagement, and favorable safety profiles, rendering them promising candidates for both preventive and therapeutic intervention in pancreatitis. Nevertheless, a comprehensive synthesis of current evidence regarding their mechanisms, bioactive constituents, and translational potential remains lacking. This review provides a rigorously categorized analysis of bioactive natural compounds (including alkaloids, quinones, terpenes, flavonoids, phenolics, and glycosides) and their molecular targets implicated in the prevention and treatment of pancreatitis. Furthermore, it critically evaluates emerging strategies for the rational engineering and optimization of plant-derived compounds, thereby offering a conceptual and mechanistic foundation for the development of novel therapeutics and innovative treatment paradigms for pancreatitis.
2 November 2026 in Food Science and Human Wellness
Pancreatic inflammation is an increasingly common worldwide health problem that requires the development of novel intervention strategies. The aim of this study is to evaluate the effectiveness of purple rice (Oryza sativa L. indica) seed coat extract (PRE) in reducing pancreatic inflammation, while also exploring the underlying mechanisms. PRE was extracted with hydrochloric acid ethanol and analyzed for its components with widely targeted components. The effects of PRE on pancreatic inflammation were evaluated through histological analysis, pancreatic function testing, gut microbial sequencing and an assessment of intestinal barrier permeability. Bioinformatics analysis was employed to predict potential PRE targets in pancreatic inflammation, including the chemokine C-C motif receptor (CCR2). The PREH and PREL groups mice received 600 mg/kgbw and 200 mg/kgbw of PRE, respectively. Western blotting, immunofluorescence assay and cytokine detection were used to investigate the mechanism of PRE ameliorating pancreatic inflammation in vivo. PRE treatment improved pancreatic function and reduced pathological pancreatic injury in mice with pancreatic inflammation. PRE treatment attenuated pancreatic oxidative stress via the CCR2/NAD(P)H dehydrogenase quinone 1 (NQO1) pathway and suppressed inflammation by inhibiting the CCR2/nuclear factor kappa B (NFκB) pathway in pancreatic inflammation mice. Additionally, PRE treatment restored intestinal barrier integrity, modulated the gut microbiota and reduced levels of E. coli in the pancreas. Our findings showed that PRE alleviated pancreatic inflammation by reducing oxidative stress and inflammation, improving pancreatic function, modulating the gut microbiota and repairing the intestinal barrier. Therefore, these results suggest that PRE is a promising functional food ingredient for promoting pancreatic health.